PRIYADHARSINI NAGARAJAN to Mutation
This is a "connection" page, showing publications PRIYADHARSINI NAGARAJAN has written about Mutation.
Connection Strength
0.131
-
Differential mutation frequencies in metastatic cutaneous squamous cell carcinomas versus primary tumors. Cancer. 2017 04 01; 123(7):1184-1193.
Score: 0.034
-
Clinical significance of BRAF V600E mutational status in capsular nevi of sentinel lymph nodes in patients with primary cutaneous melanoma. Hum Pathol. 2017 01; 59:48-54.
Score: 0.033
-
Telomerase reverse transcriptase immunohistochemical expression is sensitive but not specific for TERT gene amplification in acral melanoma. J Cutan Pathol. 2023 Sep; 50(9):845-851.
Score: 0.013
-
BRAF V600E immunohistochemistry as a useful tool in the diagnosis of melanomas with ambiguous morphologies and immunophenotypes. J Cutan Pathol. 2023 Mar; 50(3):223-229.
Score: 0.013
-
Cutaneous adnexal carcinosarcoma: Immunohistochemical and molecular evidence of epithelial mesenchymal transition. J Cutan Pathol. 2021 Apr; 48(4):526-534.
Score: 0.011
-
Regressed melanocytic nevi secondary to pembrolizumab therapy: an emerging melanocytic dermatologic effect from immune checkpoint antibody blockade. Int J Dermatol. 2019 Sep; 58(9):1045-1052.
Score: 0.009
-
Chronic myelomonocytic leukemia masquerading as cutaneous indeterminate dendritic cell tumor: Expanding the spectrum of skin lesions in chronic myelomonocytic leukemia. J Cutan Pathol. 2017 Dec; 44(12):1075-1079.
Score: 0.009
-
Giemsa is the optimal counterstain for immunohistochemical detection of BRAF V600E mutation status in pigmented melanomas. J Cutan Pathol. 2016 Aug; 43(8):722-4.
Score: 0.008